Celera Revenues Drop 21 Percent in Q2 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera's second-quarter revenues dropped almost 21 percent, it reported after the close of market on Tuesday, missing consensus Wall Street estimates.

For the three months ended June 26, Celera recorded $32.6 million in revenues, down from $41.4 million in Q2 2009, and short of the $36 million expected by analysts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.